内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NKTR 内克塔治疗

盘后交易 07-17 16:42:23 EDT

1.45

-0.02

-1.36%

盘后1.45

+0.000.00%

16:03 EDT

最高1.52	最低1.40	成交量135.26万
今开1.43	昨收1.47	日振幅8.13%
总市值2.67亿	流通市值2.37亿	总股本1.84亿
成交额195.45万	换手率0.83%	流通股本1.64亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NKTR","market":"US","secType":"STK","nameCN":"内克塔治疗","latestPrice":1.45,"timestamp":1721246400000,"preClose":1.47,"halted":0,"volume":1352647,"hourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.45,"latestTime":"16:03 EDT","volume":26147,"amount":37913.15,"timestamp":1721246581646},"delay":0,"floatShares":163623708,"shares":184019532,"eps":-0.918374,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.02,"latestTime":"07-17 16:42:23 EDT","open":1.43,"high":1.5195,"low":1.4,"amount":1954477.253887,"amplitude":0.081293,"askPrice":1.59,"askSize":5,"bidPrice":1.41,"bidSize":1529,"shortable":3,"etf":0,"ttmEps":-0.918374,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721260800000},"adr":0,"adjPreClose":1.47,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.47,"preClose":1.47,"latestTime":"09:02 EDT","volume":1,"amount":1.47,"timestamp":1721221366922},"postHourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.45,"latestTime":"16:03 EDT","volume":26147,"amount":37913.15,"timestamp":1721246581646},"volumeRatio":0.756146,"impliedVol":0.7275,"impliedVolPercentile":0.0714},"requestUrl":"/m/hq/s/NKTR","defaultTab":"news","newsList":[{"id":"2451191149","title":"内克塔治疗盘中异动 股价大涨5.00%报1.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451191149","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451191149?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:11","pubTimestamp":1721142719,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时11分，内克塔治疗股票出现异动，股价急速上涨5.00%。截至发稿，该股报1.47美元/股，成交量29.6435万股，换手率0.16%，振幅4.97%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予持有建议，20%的券商给予卖出建议，无券商给予买入建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.30%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231159941f7795&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231159941f7795&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2451622558","title":"内克塔治疗盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451622558","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451622558?lang=zh_cn&edition=full","pubTime":"2024-07-15 23:40","pubTimestamp":1721058026,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日23时40分，内克塔治疗股票出现波动，股价急速跳水5.63%。截至发稿，该股报1.34美元/股，成交量45.1759万股，换手率0.25%，振幅7.73%。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.20%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715234026af9267c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715234026af9267c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2450853508","title":"内克塔治疗盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450853508","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450853508?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:50","pubTimestamp":1720792239,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日21时50分，内克塔治疗股票出现波动，股价快速上涨5.15%。截至发稿，该股报1.43美元/股，成交量15.0526万股，换手率0.08%，振幅7.71%。内克塔治疗股票所在的生物技术行业中，整体涨幅为1.17%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712215040aef97b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712215040aef97b2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2450236198","title":"内克塔治疗盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450236198","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450236198?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:39","pubTimestamp":1720708782,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时39分，内克塔治疗股票出现波动，股价急速上涨5.23%。截至发稿，该股报1.40美元/股，成交量56.0397万股，换手率0.30%，振幅5.64%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予持有建议，20%的券商给予卖出建议，无券商给予买入建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.75%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711223942aef93fef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711223942aef93fef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2450089740","title":"内克塔治疗盘中异动 下午盘股价大跌5.04%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450089740","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450089740?lang=zh_cn&edition=full","pubTime":"2024-07-09 02:39","pubTimestamp":1720463997,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日02时39分，内克塔治疗股票出现异动，股价大幅下跌5.04%。截至发稿，该股报1.23美元/股，成交量87.7987万股，换手率0.48%，振幅8.53%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予持有建议，20%的券商给予卖出建议，无券商给予买入建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.88%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709023957af911be1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709023957af911be1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2449296477","title":"内克塔治疗盘中异动 早盘股价大跌5.96%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449296477","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449296477?lang=zh_cn&edition=full","pubTime":"2024-07-05 22:37","pubTimestamp":1720190222,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日22时37分，内克塔治疗股票出现异动，股价急速下跌5.96%。截至发稿，该股报1.22美元/股，成交量32.9436万股，换手率0.18%，振幅6.54%。内克塔治疗股票所在的生物技术行业中，整体涨幅为1.19%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705223702941f4760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705223702941f4760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2448898244","title":"内克塔治疗盘中异动 早盘快速上涨5.13%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448898244","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448898244?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:16","pubTimestamp":1720016194,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时16分，内克塔治疗股票出现波动，股价快速拉升5.13%。截至发稿，该股报1.23美元/股，成交量38.4164万股，换手率0.21%，振幅5.13%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.43%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703221634aef7cb59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703221634aef7cb59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2448157608","title":"内克塔治疗盘中异动 股价大跌5.74%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448157608","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448157608?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:45","pubTimestamp":1719927942,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日21时45分，内克塔治疗股票出现异动，股价大幅下跌5.74%。截至发稿，该股报1.15美元/股，成交量10.0613万股，换手率0.05%，振幅6.15%。内克塔治疗股票所在的生物技术行业中，整体跌幅为1.08%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702214543aef798e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702214543aef798e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2448150918","title":"内克塔治疗盘中异动 快速拉升5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448150918","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448150918?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:30","pubTimestamp":1719840653,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时30分，内克塔治疗股票出现异动，股价大幅拉升5.65%。截至发稿，该股报1.31美元/股，成交量1.1087万股，换手率0.01%，振幅0.08%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.23%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。该公司拥有肿瘤学、免疫学和病毒学研究药物的全资研发管线，以及一系列获批的合作药物。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213054968186b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213054968186b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2446368510","title":"内克塔治疗盘中异动 早盘股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446368510","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446368510?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:55","pubTimestamp":1719582939,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时55分，内克塔治疗股票出现波动，股价急速上涨6.14%。截至发稿，该股报1.21美元/股，成交量28.4873万股，换手率0.15%，振幅6.58%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.24%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。该信息摘要如下：奥本海默控股分析师Jay Olson维持$内克塔治疗 $持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628215539941f2538&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628215539941f2538&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2446155320","title":"内克塔治疗盘中异动 大幅上涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446155320","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446155320?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:44","pubTimestamp":1719495885,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时44分，内克塔治疗股票出现波动，股价急速拉升5.53%。截至发稿，该股报1.15美元/股，成交量9.9414万股，换手率0.05%，振幅5.53%。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.19%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。该信息摘要如下：奥本海默控股分析师Jay Olson维持$内克塔治疗 $持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721444696817846&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721444696817846&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2446392325","title":"内克塔治疗盘中异动 早盘股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446392325","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446392325?lang=zh_cn&edition=full","pubTime":"2024-06-26 22:42","pubTimestamp":1719412945,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日22时42分，内克塔治疗股票出现异动，股价大幅下跌5.44%。截至发稿，该股报1.01美元/股，成交量30.0482万股，换手率0.16%，振幅6.07%。内克塔治疗股票所在的生物技术行业中，整体跌幅为0.86%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。该信息摘要如下：奥本海默控股分析师Jay Olson维持$内克塔治疗 $持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626224225968171b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626224225968171b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2446849220","title":"内克塔治疗盘中异动 早盘股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446849220","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446849220?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:30","pubTimestamp":1719322230,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时30分，内克塔治疗股票出现异动，股价急速下挫5.13%。截至发稿，该股报1.11美元/股，成交量4290股，换手率0.00%，振幅0.00%。机构评级方面，在所有4家参与评级的机构中，75%的券商给予持有建议，25%的券商给予卖出建议，无券商给予买入建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.00%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213030aef686c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213030aef686c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2433721352","title":"内克塔治疗盘中异动 大幅上涨14.00%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433721352","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433721352?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:34","pubTimestamp":1715175244,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时34分，内克塔治疗股票出现波动，股价急速拉升14.00%。截至发稿，该股报1.71美元/股，成交量28.9405万股，换手率0.16%，振幅5.67%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.16%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821340487e0975f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821340487e0975f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2433789790","title":"内克塔治疗盘中异动 早盘快速跳水5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433789790","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433789790?lang=zh_cn&edition=full","pubTime":"2024-05-07 23:07","pubTimestamp":1715094472,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日23时07分，内克塔治疗股票出现波动，股价快速下挫5.45%。截至发稿，该股报1.56美元/股，成交量25.3303万股，换手率0.14%，振幅5.76%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.86%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507230753861eb821&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507230753861eb821&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2432335331","title":"内克塔治疗盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432335331","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432335331?lang=zh_cn&edition=full","pubTime":"2024-05-04 03:16","pubTimestamp":1714763807,"startTime":"0","endTime":"0","summary":"北京时间2024年05月04日03时16分，内克塔治疗股票出现异动，股价大幅下挫5.09%。截至发稿，该股报1.59美元/股，成交量81.574万股，换手率0.44%，振幅8.98%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.74%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050403164787e8584f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050403164787e8584f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0},{"id":"2432978068","title":"Nektar Therapeutics    预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432978068","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432978068?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:32","pubTimestamp":1714735976,"startTime":"0","endTime":"0","summary":"   * Nektar Therapeutics    预计将在5月7日公布截至2024年3月31日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，3位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山的公司的营收将从去年同期的2159万美元降至1534.2万美元，降幅为29.0%。* LSEG 分析师对 Nektar Therapeutics 的平均预期是每股亏损 19 美分。* 华尔街对 Nektar Therapeutics 的 12 个月目标价中位数为 2.00 美元，高于其上次收盘价 1.67 美元。5月3日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","NKTR"],"gpt_icon":0},{"id":"2432957601","title":"内克塔治疗盘中异动 大幅上涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432957601","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432957601?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:30","pubTimestamp":1714656658,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时30分，内克塔治疗股票出现异动，股价大幅上涨5.45%。截至发稿，该股报1.74美元/股，成交量28.8669万股，换手率0.16%，振幅0.00%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.00%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502213059861eaad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502213059861eaad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2432509094","title":"内克塔治疗盘中异动 早盘股价大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432509094","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432509094?lang=zh_cn&edition=full","pubTime":"2024-05-01 23:00","pubTimestamp":1714575653,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日23时00分，内克塔治疗股票出现波动，股价快速拉升5.48%。截至发稿，该股报1.54美元/股，成交量18.9839万股，换手率0.10%，振幅5.82%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.63%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012300547925a28b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012300547925a28b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NKTR"],"gpt_icon":0},{"id":"2431499865","title":"内克塔治疗盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431499865","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431499865?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:31","pubTimestamp":1714397516,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时31分，内克塔治疗股票出现异动，股价急速上涨5.15%。截至发稿，该股报1.39美元/股，成交量1.7172万股，换手率0.01%，振幅2.27%。机构评级方面，在所有4家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。内克塔治疗股票所在的生物技术行业中，整体涨幅为0.18%。内克塔治疗公司简介：Nektar Therapeutics是一家生物制药公司。在病毒学方面，该公司认为选择性免疫调节剂可用于解决人类的病毒感染问题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131567924ebea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292131567924ebea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NKTR","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nektar.com","stockEarnings":[{"period":"1week","weight":0.1951},{"period":"1month","weight":0.2564},{"period":"3month","weight":0.0889},{"period":"6month","weight":1.6727},{"period":"1year","weight":1.6606},{"period":"ytd","weight":1.6018}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nektar Therapeutics于1990年在加州成立，并于1998年重新在特拉华州注册。这是临床阶段生物制药公司，其利用PEG修饰和先进的聚合物共轭技术平台开发一个管道的候选药物。这些平台是为了认识其作用机制确保新分子实体的发展。当前专用管道包括跨多个治疗领域包括肿瘤、疼痛、抗感染和免疫领域候选药物。研究和开发活动涉及两种小分子和生物药物的候选。公司通过使用专有先进聚合物共轭技术来修改药效基因创建新的分子实体的化学结构，从而来创建创新候选药物。司收入来源于与伙伴合作协议，它可以接收合同研究支付、根据临床进展和监管进展或净销售额获得里程碑付款、版税或生产收入。","yearOnYearQuotes":[{"month":1,"riseRate":0.566667,"avgChangeRate":0.047978},{"month":2,"riseRate":0.5,"avgChangeRate":0.00268},{"month":3,"riseRate":0.4,"avgChangeRate":0.004229},{"month":4,"riseRate":0.433333,"avgChangeRate":0.006304},{"month":5,"riseRate":0.366667,"avgChangeRate":0.006185},{"month":6,"riseRate":0.387097,"avgChangeRate":-0.018715},{"month":7,"riseRate":0.451613,"avgChangeRate":-0.011613},{"month":8,"riseRate":0.466667,"avgChangeRate":0.036795},{"month":9,"riseRate":0.466667,"avgChangeRate":0.014605},{"month":10,"riseRate":0.366667,"avgChangeRate":-0.026724},{"month":11,"riseRate":0.7,"avgChangeRate":0.094193},{"month":12,"riseRate":0.633333,"avgChangeRate":0.03444}],"exchange":"NASDAQ","name":"内克塔治疗","nameEN":"Nektar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"内克塔治疗,NKTR,内克塔治疗股票,内克塔治疗股票老虎,内克塔治疗股票老虎国际,内克塔治疗行情,内克塔治疗股票行情,内克塔治疗股价,内克塔治疗股市,内克塔治疗股票价格,内克塔治疗股票交易,内克塔治疗股票购买,内克塔治疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"内克塔治疗(NKTR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供内克塔治疗(NKTR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}